Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

Clinical trial NCT04410796 · RECRUITING

Trial details

NCT number: NCT04410796
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer

Start date: 2020-05-28
Primary completion: 2027-05-01
Enrollment: 571

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.